3. Pharmacopoeia: Indian, British, and United States Standards

PHARMACOPOEIA

Pharmacopoeia is an official book of standards for drugs, dosage forms, pharmaceutical aids, and related materials published under the authority of a country’s own government. It contains accepted standards for identity, purity, strength, and quality of medicines. In simple words, a pharmacopoeia tells pharmacists, doctors, manufacturers, and regulators what the correct standard of a medicine should be. Many countries publish their own pharmacopoeias, such as the Indian Pharmacopoeia (IP), British Pharmacopoeia (BP), and United States Pharmacopoeia (USP).

For pharmacy students, pharmacopoeia is an important subject because it connects theory with real pharmaceutical practice. When you study pharmacopoeial standards, you learn how medicines are evaluated, how quality is checked, and how legal requirements are applied in healthcare and industry. This knowledge is useful not only in examinations but also in practical pharmacy work, where standards must be followed carefully to protect patient safety.

FOR PDF NOTES, READ BELOW:

INDIAN PHARMACOPOEIA (IP)

Indian Pharmacopoeia (IP) is the official document used in India for the overall quality control and assurance of pharmaceutical products. It helps ensure that medicines sold in the country are safe, effective, and affordable. The IP contains authoritative procedures for analysis and specifications for drugs and pharmaceutical substances. It has legal status under the Second Schedule of the Drugs & Cosmetics Act, 1940 and the Rules, 1945. In practice, IP standards are used to check the identity, purity, and strength of medicines and other pharmaceutical substances.

The Indian Pharmacopoeia is published by the Indian Pharmacopoeia Commission (IPC) under the Ministry of Health and Family Welfare, Government of India. These standards are not only technical guidelines but also legally accepted references. If any dispute arises regarding the quality of a medicine, IP standards can be used in quality assurance work and even in a court of law. This is why the IP is considered one of the most important documents in Indian pharmacy practice.

From a student’s point of view, the IP teaches the language of standardization. It helps future pharmacists understand why medicine quality must be measured scientifically. It also shows how the government protects public health through official standards. This is especially important in a country like India, where a large population depends on safe and affordable medicines.

History of Indian Pharmacopoeia

The history of the Indian Pharmacopoeia began long before independence. In 1833, a committee of the East India Company’s Dispensary recommended the publication of a pharmacopoeia and the Bengal Pharmacopoeia. Later, the General Conspectus of Medicinal Plants was published in 1844, listing many commonly used indigenous remedies. These early efforts showed the need for an organized reference book for Indian medicines.

A major step came in 1868 with the publication of the first Indian Pharmacopoeia. It covered both drugs from the British Pharmacopoeia of 1867 and indigenous drugs used in India. A supplement was published in 1869 to include vernacular names of indigenous drugs and plants. However, from 1885 the British Pharmacopoeia became official in India. Later, in 1927, a Drug Enquiry Committee recommended the publication of a national pharmacopoeia. This recommendation became a turning point in India’s pharmaceutical history.

The history of IP is important because it reflects India’s growth from colonial dependence to scientific self-reliance. It also shows how traditional knowledge and modern standards slowly came together to form a national pharmaceutical system. For exam preparation, students should remember that the IP developed gradually and became a powerful tool for Indian medicine regulation.

Editions of Indian Pharmacopoeia

Edition	Year of Publication	Addendum(s) Released
First	1955	1960
Second	1966	1975
Third	1985	1989 (1st), 1991 (2nd)
Fourth	1996	2000 (1st), 2002 (2nd), 2005 (3rd)
Fifth	2007	2008
Sixth	2010	2012
Seventh	2014	2015
Eighth	2018	2019
Ninth	2022	Not released yet

This table is useful for memorizing the publication history of the Indian Pharmacopoeia. In exams, questions are often asked about the year of publication, addendums, and the evolution of each edition. Students should study the sequence carefully because the editions show how pharmaceutical standards changed with the development of science and technology.

Salient Features – 1st Edition (1955)

• Monograph titles were given in Latin language.
• Abbreviated titles were written below Latin titles.
• English titles were placed below abbreviated titles.
• Weights and measures were given in the metric system.
• Doses were expressed in both metric and English systems.
• Descriptive terms such as free soluble, very soluble, and sparingly soluble were used where exact solubility was not known.
• Lists of preparations were given at the end of some monographs.

The first edition was important because it laid the foundation for a standardized Indian reference system. At that time, medicine standardization was still developing, so the language and format reflected the older style of pharmacopoeial writing. This edition also shows the transition from traditional presentation methods to more modern scientific documentation.

Salient Features – 2nd Edition (1966)

• Monograph titles changed from Latin to English.
• Doses were expressed in metric system only.
• Solubility was expressed in parts of solvent per unit part of solute.
• Drug preparations were provided below the monograph of the parent drug.
• New analytical techniques such as non-aqueous titrimetry and column chromatography were included.

The second edition marked an important modernization step. English titles made the pharmacopoeia easier to understand and more practical for Indian professionals. The inclusion of new analytical methods also showed that the document was becoming more scientific and closely aligned with laboratory practice.

Salient Features – 3rd Edition (1985)

• New analytical techniques such as Flame Photometry, Fluorimetry, Electrophoresis, and Photometric Haemoglobinometry were added.
• Gas Liquid Chromatography was used for alcohol determination in preparations.
• Dissolution test was introduced for tablet evaluation.
• Disintegration test was modified.
• Name changes were made, such as Acetylsalicylic acid to Aspirin.
• Microbial limit test was included for pharmaceutical aids and oral liquid preparations.

This edition is important because it brought stronger quality control methods into the Indian system. By adding microbiological and instrumental methods, the IP became more advanced and more suitable for modern pharmaceutical manufacturing. It also reflected the growing importance of dosage-form performance and product safety.

Salient Features – 4th Edition (1996)

• 1149 monographs and 123 appendices were included in 2 volumes.
• Computer-generated structural formulae were introduced.
• Some substances were renamed, such as Hyoscine Hydrobromide for Scopolamine Hydrobromide.
• HPLC was widely used, including for insulin assay.
• Bacterial endotoxin test was introduced as an alternative to the pyrogen test.
• ORS-citrate formula was adopted instead of ORS-bicarbonate.

The fourth edition showed a clear shift toward modern analytical technology. High-performance liquid chromatography and bacterial endotoxin testing are examples of advanced methods that improved reliability and accuracy. This edition also demonstrates how the Indian Pharmacopoeia continued to follow global trends while remaining suitable for Indian healthcare needs.

Salient Features – 5th Edition (2007)

• General chemical tests were replaced with IR and UV spectrophotometric tests.
• Tests for bacterial toxins were included.
• Labelling and storage details were provided at the end of monographs.
• General monographs for dosage forms were grouped at the beginning of Volume II.
• Separate sections were created for vaccines, herbs, blood products, and biotechnology products in Volume III.
• Limit of bacterial contamination was introduced for all medicinal products.

This edition improved organization and clarity. It also reflected the increasing importance of biotechnology, biological products, and microbial safety in pharmacy. For students, this edition is a good example of how pharmacopoeias adapt to new scientific developments.

Salient Features – 6th Edition (2010)

• There were 3 hard bound volumes.
• Total 1918 monographs were included, with 287 new additions.
• Categorisation, dosage, and available strength were added.
• Traditional tests were replaced with IR and UV spectrophotometry.
• Cross-referencing was eliminated.
• Chromatography was applied extensively.
• Pyrogen testing was eliminated up to certain limits.
• Herbal drug monographs were added.
• Authenticity certificate was included.

The sixth edition reflected an even stronger move toward scientific precision and streamlined reference structure. Herbal medicines were also given more importance, which is significant in the Indian context because traditional medicines continue to play a role in healthcare. This edition made the IP more practical for both students and professionals.

Salient Features – 7th Edition (2014)

• Total 2548 monographs were included, including 577 new monographs.
• 19 monographs and 1 general chapter on radiopharmaceuticals were added.
• The edition was published in 4 hard bound volumes plus DVD.
• Veterinary monographs became an important part of the edition.
• Chromatographic methods were mentioned extensively.
• Pyrogen testing was virtually eliminated.
• Irrelevant monographs were removed.
• Herbal monographs were added.
• Authenticity certificate was included.

This edition expanded the scope of the pharmacopoeia even more. The inclusion of radiopharmaceuticals and veterinary products showed that the IP was becoming broader and more comprehensive. It was no longer limited only to ordinary medicines, but covered a wider range of pharmaceutical and healthcare substances.

Salient Features – 8th Edition (2018)

• General chemical tests and TLC were almost eliminated.
• IR, UV, and HPLC were given more importance.
• Chromatographic methods became more comprehensive.
• Liquid chromatography was upgraded for harmonisation with international pharmacopoeias.
• Bacterial Endotoxin Test replaced the pyrogen test.
• An index was introduced in Volume I for easier access.
• 53 new Fixed Dose Combination monographs were added, including 25 not found in any other pharmacopoeia.
• General chapters such as volumetric glassware, conductivity, dissolution test, and disintegration test were revised.

The eighth edition is highly important because it improved harmonisation with international standards. This is very useful for students who want to understand how Indian standards connect with global pharmaceutical practice. The addition of many fixed dose combinations also shows the practical needs of Indian healthcare.

Salient Features – 9th Edition (2022)

• 92 new drug monographs were added.
• 27 new APIs were included.
• 3 new biotechnology-derived therapeutic products were added.
• 2 new herbs and herbal products were included.
• 33 new dosage forms for chemicals were added.
• 4 new vaccines and immunosera were included.
• 12 new general chapters were added.
• The edition aligns with National Health Programmes and the National List of Essential Medicines of India.

The ninth edition shows that the Indian Pharmacopoeia continues to grow with modern healthcare needs. It covers more biotechnology products, herbal products, vaccines, and dosage forms. This makes it a very current and practical reference for students, teachers, manufacturers, and regulatory professionals.

BRITISH PHARMACOPOEIA (BP)

The British Pharmacopoeia is published annually and contains the standards required for maintaining the quality of medicinal substances in the United Kingdom. It is widely used by professionals and organizations involved in pharmaceutical research, development, manufacturing, and testing. Like the Indian Pharmacopoeia, the BP plays an important role in ensuring medicine quality and safety.

The BP is especially useful for international comparison because it reflects standards accepted in one of the major pharmaceutical systems in the world. Students should understand that pharmacopoeias are not just books of formulas or names; they are powerful official references that guide product quality, testing methods, and professional practice.

History of BP

• 1864: First edition of BP published, compiled from Pharmacopoeia Londinensis 1618, Edinburgh Pharmacopoeia 1699, and Dublin Pharmacopoeia 1807.
• 1874: Second edition.
• 1885: Third edition, with addendum in 1890.
• 1898: Fourth edition.
• 1914: Fifth edition.
• 1928: Commission was made.
• 1932: Sixth edition, with diagnostic materials integrated and standard tests for antitoxins and insulin.
• 1948: Seventh edition, with generic names, disintegration tests, sterilisation methods, sex hormones, and penicillin monographs.
• 1953: Eighth edition, with titles in English.
• 1958: Ninth edition, with 160 new monographs, tranquilisers, and spectrophotometry.
• 1963: Tenth edition.
• 1970: Medicines Order passed.
• 1980: Thirteenth edition, the first prepared under the Medicines Act, published in two volumes.
• 1993: Authoritative standards for 130 years.
• 2007-2010, 2013, 2014, 2016, 2018, 2020: Further editions.
• 2021: Latest edition.

The British Pharmacopoeia history shows a long tradition of official standard setting. It evolved steadily from older regional pharmacopoeias into a modern national reference system. This history is helpful for students because it explains how pharmacopoeial science developed internationally over time.

BP 2021 – Key Features

• 30 new BP monographs and 20 new Ph. Eur. monographs were added.
• 171 BP monographs were amended.
• All monographs from Ph. Eur. 10th edition and supplements 10.1 and 10.2 were included.
• Tracked changes functionality was introduced.
• Timeline functionality was streamlined.
• Archive access was improved through better navigation.
• 8 new BPCRS were added.

The 2021 edition is user-friendly and digitally improved. It reflects the modern shift toward online access and better searchable content. This is especially helpful for professionals working in testing, formulation development, and regulatory compliance.

Volumes of BP

• Volumes I & II: Medicinal substances.
• Volume III: Formulated preparations, blood-related preparations, immunological products, radiopharmaceutical preparations, surgical materials, and homeopathic preparations.
• Volume IV: Appendices, infrared reference spectra, and index.
• Volume V: Veterinary preparations.
• Volume VI: CD-ROM version, BP, BP veterinary, and British Approved Names.

UNITED STATES PHARMACOPOEIA (USP)

The United States Pharmacopoeia is the official pharmacopoeia of the United States, published annually by the United States Pharmacopeial Convention, a non-profit organization. It is published in a combined form with the National Formulary as the USP-NF. The USP is one of the most widely respected pharmacopoeial standards in the world and is commonly used in research, industry, and quality control.

USP standards are highly valuable because they help maintain consistency in medicine quality and testing. Many pharmaceutical companies use USP references to ensure that their products meet internationally accepted standards. For students, USP is important because it provides a global perspective on how medicines are standardized and regulated.

History of USP

• 1817: Dr. Lyman Spalding proposed a plan for a national pharmacopoeia.
• 1820: First edition of USP was published with 217 drugs and 272 pages.
• 1905: Ninth edition was published, titled USP VIII as an 8th revision.
• 1974 (5th July): USP and NF were unified and published in a single volume.
• 1990: USP 22 combined with NF 17.
• 2013 (November): USP 37 and NF 32 were published, with 4700+ monographs and 270+ general chapters.
• 2016: USP 39-NF 34 with 4900+ monographs and 300+ general chapters.
• 2018: USP 41-NF 36 with 4900 monographs and 350 chapters.
• 2020: USP 43-NF 38, the last edition in print/USB format, after which it became online only.

The USP has a long history of growth and modernization. It started as a small national reference and developed into a major global standard. The move toward online-only access shows how pharmacopoeial resources are adapting to digital learning and professional needs.

USP-NF Benefits and Applications

• Ensures compliance with required U.S. quality standards.
• Helps professionals work to world-recognized standards of precision and accuracy.
• Validates test results against proven benchmarks.
• Supports establishment and validation of in-house SOPs and specifications.
• Speeds up new product development and approvals.

USP-NF is useful not only in the United States but also in many global pharmaceutical operations. Its monographs and standards help manufacturers, analysts, and regulators maintain confidence in the quality of medicinal products. This makes it a very important reference for advanced pharmacy practice.

NATIONAL FORMULARY OF INDIA (NFI)

The National Formulary of India is an authoritative guide for prescribing, dispensing, and administering medicines for healthcare professionals. It is useful for developing and supporting national drug policies in India. While pharmacopoeias mainly give official standards for medicines, the formulary gives practical guidance on medicine use, making it highly useful in healthcare practice.

For students and professionals, the NFI serves as a bridge between quality standards and practical medicine use. It helps ensure that treatment decisions are scientifically sound and consistent with national healthcare needs. This is why the formulary is an important part of pharmacy education and public health planning.

Chronology of NFI

• First Edition – 1960.
• Second Edition – 1966.
• Third Edition – 1979.
• Fourth Edition – 2011.
• Fifth Edition – 2016.
• Sixth Edition (Current) – 2021.

The National Formulary of India is updated periodically to reflect changing medical needs and national priorities. It remains an important reference for rational medicine use in India.